4 results
Approved WMOPending
The objective of this clinical investigation is to evaluate the short- and long-term clinical feasibility of the Provox FreeHands FlexiVoice, in combination with the currently available attachments, and explore its limitations and advantages.
Approved WMOCompleted
Efficacy and safety during 24 treatment weeks.
Approved WMOCompleted
To investigate the clinical feasibility of the TW22.
Approved WMOCompleted
Primary: To demonstrate non-inferiority of RELVAR 100/25 once-daily to SERETIDE 250/50 twice-daily in adult and adolescent subjects 12 years of age and older with persistent asthma,adequately controlled on twice-daily ICS/LABA. Secondary: Adverse…